VITM24 logo

Prospective Summit Directors

  • Aldo Badano, FDA
  • Predrag Bakic, Lund University, Sweden
  • Kristina Bliznakova, Bulgaria
  • Hilde Bosmans, KU Leuven, Belgium
  • Ann-Katherine Carton, GE, France
  • Alex Frangi, University of Leeds, UK
  • Doris Fuertinger, Fresenius Medical Care, Germany
  • Stephen Glick, FDA
  • Paul Kinahan, University of Washington
  • Andrew Maidment, University of Pennsylvania
  • Ehsan Samei, CVIT, Duke University
  • Ioannis Sechopoulos, Radboud University, Netherlands
  • Rie Tanaka, Kanazawa University, Japan

Local Arrangement Committee

  • Ehsan Abadi, CVIT, Duke University
  • Ehsan Samei, CVIT, Duke University
  • Paul Segars, CVIT, Duke University
  • Joseph Lo, CVIT, Duke University

Summit Details

The two and a half – day Summit will include

  1. Presentations by leading scientists, practitioners, and developers of related scholarship,
  2. Workshops,
  3. Proffered presentations, and
  4. Industry expo

The intended audiences are all individuals interested in the development and medical use of virtual tools including biomedical engineers, physicists, radiologists, radiation oncologists, clinical practitioners, regulators, and vendors. The topics are informed by the following broad categories:

  • Computational human models
  • Computational models of diseases
  • Computational models of imaging systems
  • Computational models of interventional hardware
  • Computational models of interventional processes
    Imaging assessment models
  • Data interpretation models
  • Standards and data formats for VT
  • VT and its utility and application to AI
  • Hybrid clinical and virtual trials
  • VT and its relevance and role in regulatory science
  • Verification, validation, and inference of VT results
  • Variability quantification and its representation in VT
  • Limits of approximation and extrapolation of VT results
  • Case example applications of VT
  • Application of VT to clinical practice
  • Future priorities and application of VT